Biomerica, Inc.
BMRA
$2.38
-$0.02-0.63%
NASDAQ
| 11/30/2025 | 08/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -12.32% | 84.25% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -12.32% | 84.25% | |||
| Cost of Revenue | 21.23% | -3.73% | |||
| Gross Profit | -87.97% | 273.77% | |||
| SG&A Expenses | -7.44% | 24.53% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.40% | 8.00% | |||
| Operating Income | -22.81% | 28.52% | |||
| Income Before Tax | -26,400.00% | 100.32% | |||
| Income Tax Expenses | 66.67% | -40.00% | |||
| Earnings from Continuing Operations | -66,100.00% | 100.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -66,100.00% | 100.13% | |||
| EBIT | -22.81% | 28.52% | |||
| EBITDA | -23.22% | 28.75% | |||
| EPS Basic | -56,837.50% | 100.11% | |||
| Normalized Basic EPS | -23,650.00% | 100.28% | |||
| EPS Diluted | -56,837.50% | 100.11% | |||
| Normalized Diluted EPS | -23,650.00% | 100.28% | |||
| Average Basic Shares Outstanding | 10.21% | 19.57% | |||
| Average Diluted Shares Outstanding | 10.21% | 19.57% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||